0512.HK
0512.HK
BMG210A71016
GRAND PHARMA
Loading chart...

Company Profile

Grand Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials. The company offers respiratory, ophthalmology, cerebro-cardiovascular emergency, and biotechnology related products. It manufactures and sells pharmaceutical, taurine, agrochemicals, chemical medicine, and amino acid series products. In addition, the company provides bio-pesticides and additives; disposal surgical products; and Chinese medicine, and health food products. The company has a strategic cooperation agreement with the Eye Hospital of Wenzhou Medical University in the field of ophthalmic drug research and development. It operates in the People's Republic of China, the rest of Asia, the United States, Europe, and internationally. The company has a strategic partnership with the University of Hong Kong for the research and development of drugs in the field of anti-infection and the industrialization of the research results. The company was formerly known as China Grand Pharmaceutical and Healthcare Holdings Limited. The company was incorporated in 1995 and is based in Central, Hong Kong.

Related stocks

RGC
RGC • Hong Kong SAR China
Regencell Bioscience Holdings L
7.35 USD
3.64B USD 1Y -60.7%
HCM.L
HCM.L • Hong Kong SAR China
HUTCHMED (CHINA) LIMITED ORD US
203 GBp
2.33B USD 1Y -11.8%
HCM
HCM • Hong Kong SAR China
HUTCHMED (China) Limited
14.1 USD
2.45B USD 1Y -16.6%
3933.HK
3933.HK • Hong Kong SAR China
UNITED LAB
7.52 HKD
1.89B USD 1Y -46.9%
0867.HK
0867.HK • Hong Kong SAR China
CMS
10.54 HKD
3.27B USD 1Y -23.9%
2005.HK
2005.HK • Hong Kong SAR China
SSY GROUP
2.67 HKD
975.57M USD 1Y -10.6%
0460.HK
0460.HK • Hong Kong SAR China
SIHUAN PHARM
0.74 HKD
859.65M USD 1Y -55.4%
0570.HK
0570.HK • Hong Kong SAR China
TRAD CHI MED
1.27 HKD
815M USD 1Y -47.1%

Key Metrics & Overview

Detailed metrics & financial data of the company

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
37.7% p.a.
Max Drawdown (5Y)
-53.5%
Sharpe Ratio (5Y)
-0.22
Beta Factor
0.68
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (37.7% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -63.4% in the extended horizon.
ende